EIM
DERM icon

Essex Investment Management’s Journey Medical DERM Stock Holding History

Essex Investment Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-345,977
Closed -$2.67M – 315
2025
Q4 		$2.67M Sell
345,977
-8,044
-2% -$63.1K 0.41% 94
2025
Q3 		$2.52M Buy
354,021
+125,818
+55% +$913K 0.39% 103
2025
Q2 		$1.64M Buy
+228,203
New +$1.58M 0.3% 121
2022
Q4 		– Sell
-1,400
Closed -$3K – 402
2022
Q3 		$3K Hold
1,400
– – ﹤0.01% 401
2022
Q2 		$5K Buy
+1,400
New +$5.54K ﹤0.01% 407

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Essex Investment Management's DERM Position: Q1 2026 in Review

Essex Investment Management sold out of Journey Medical (DERM) in Q1 2026, closing a stake of 345,977 shares — an estimated $2.67M sold.

Essex Investment Management first reported a position in DERM in Q2 2022 and held it in 5 quarters. The position peaked at $2.67M in Q4 2025. 72 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Essex Investment Management reported no remaining Journey Medical position as of Q1 2026 after selling out during the quarter.
  • Essex Investment Management sold 345,977 Journey Medical shares in Q1 2026, an estimated $2.67M.
  • Essex Investment Management first reported a position in Journey Medical in Q2 2022 and held it in 5 quarters.
  • Essex Investment Management's Journey Medical position peaked at $2.67M in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.